Phase 2 Dose-Finding Study in Patients with Gout Using SEL-212, a Novel PEGylated Uricase (SEL-037) Combined with Tolerogenic Nanoparticles (SEL-110)
Article in Rheumatology and Therapy (April 2023)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
Article in Rheumatology and Therapy (April 2023)
Article in International Journal of Rheumatic Diseases (March 2023)
Article in Journal of Clinical Medicine (February 2023)